A Novel Needle-Based X-Ray System

Information

  • Research Project
  • 7294924
  • ApplicationId
    7294924
  • Core Project Number
    R44CA112683
  • Full Project Number
    5R44CA112683-03
  • Serial Number
    112683
  • FOA Number
    PA-06-20
  • Sub Project Id
  • Project Start Date
    2/1/2005 - 19 years ago
  • Project End Date
    12/31/2008 - 15 years ago
  • Program Officer Name
    DEYE, JAMES
  • Budget Start Date
    9/1/2007 - 17 years ago
  • Budget End Date
    12/31/2008 - 15 years ago
  • Fiscal Year
    2007
  • Support Year
    3
  • Suffix
  • Award Notice Date
    8/9/2007 - 17 years ago

A Novel Needle-Based X-Ray System

[unreadable] DESCRIPTION (provided by applicant): The long-term objective of the project is to develop, clinically test and commercialize the novel insertable x-ray device developed by AXT. This portable x-ray needle, is intended for delivery of low energy, high RBE radiation directly to the tumour beds and is considered to be a viable alternative to radioactive sources used in the High Dose Rate Brachytherapy. The main advantages of AXT's x-ray device include such features as a controllable on/off mode, exceptional stability of the produced radiation, adjustable dose rate, and the ability to function in a conventional operating room with almost no radiological exposure to staff. The initial application of the device is the accelerated partial breast irradiation. The main goal of the Phase II project is to design, build and test a new model of the x-ray needle with an elevated dose rate of the produced radiation (1Gy/min at 10mm in tissue). Other goals include the development of low-energy (8-18 keV) dosimetry protocols and a treatment planning approach involving the x-ray needle. To achieve the stated goals the following specific aims of the project have to be fulfilled. The specific aims of the project are: (i) design, build and test an ellipsoidal and Johansson type concentrators fabricated from a Highly Oriented Pyrolytic Graphite, (2) incorporate the concentrators into an optical collimator, (3) integrate the collimators into an x-ray needle, (4) perform measurements of dose rate and dose rate spatial distribution (isodose), (5) design and build a balloon applicator and test it jointed with an x-ray needle, (6) install an x-ray needle device in a conventional movable arm. The potential market for such device is significant. It is estimated that more than 275,000 women in the United States are annually diagnosed with breast cancer and about 50% of them are treated with radiotherapy. Development of the new model of AXT's insertable x-ray device offers hope and promise for cure and improvement to the quality of life for many affected people. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R44
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    380000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
    NCI:380000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ADVANCED X-RAY TECHNOLOGY, INC.
  • Organization Department
  • Organization DUNS
    609810333
  • Organization City
    BIRMINGHAM
  • Organization State
    MI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    48009
  • Organization District
    UNITED STATES